Ads
related to: cancer cells, anti-cancer treatment- Dosing & Administration
Learn about dosing and
administration now
- Mechanism of Action
Learn about the MOA
of a new treatment option
- Dosing & Administration
envita.com has been visited by 10K+ users in the past month
Search results
Bone Cancer Breakthrough: UCL’s New T-Cell Therapy Shows Promise
SciTechDaily· 2 hours agoA new immunotherapy developed at UCL using engineered immune cells has shown promising preclinical...
Cancer treatment may work best at the right time of day
Futurity· 4 hours agoThe circadian clock can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy,...
New immunotherapy could treat cancer in the bone
Medical Xpress· 2 hours agoOsteosarcoma is the most common bone cancer in teenagers but is still relatively rare, with around 160 new cases each year in the UK. Meanwhile, more...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 3 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
...Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer...
FOX 4 Kansas City· 5 days agoSHANGHAI, May 24, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing groundbreaking new medicines for the treatment of cancer ...
Glucocorticoids paradoxically promote steroid resistance in B cell acute lymphoblastic leukemia...
Nature· 13 hours agoResistance to glucocorticoids (GC) is a major obstacle for the treatment of pediatric B-cell acute lymphoblastic leukemia (B-ALL). Here, the authors report ...
...Photoimmunotherapy in Combination with anti-PD-1 for First Line Recurrent...and/or Metastatic...
Lodi News-Sentinel· 5 days agoThe data will be presented in a poster at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO 2024) on June...
From Robust Response to Rapid Resistance
MedPage Today· 5 days agoDemonstrating efficacy across multiple tumor types, there is no question that ICIs have revolutionized our approach to treatment and are arguably the...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 1 day agoGlycoNex and PrecisemAb Sign Technology Licensing Agreement to Advance Development of Novel Anti-Glycan Antibodies for Cancer Therapy PR Newswire NEW TAIPEI ...
BostonGene Immune Profiling Platform Shows Promise in Predicting Cancer Immunotherapy Benefit
GenomeWeb News· 5 days agoThe firm and its scientific collaborators detailed the development, training, and initial validation of the platform this month in Cancer Cell, noting that ...